Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  De Felice, Bruna ^a   Mondola, Paolo ^b   Sasso, Anna ^b   Orefice, Giuseppe ^b   Bresciamorra, Vincenzo ^b   Vacca, Giovanni ^b   Biffali, Elio ^c   Borra, Marco ^c   Pannone, Raimondo ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

IFN ; microRNA; Multiple sclerosis; sncRNA; snorRNAs

Indexed keywords

BETA INTERFERON; MICRORNA 26A; MICRORNA 26A-5P; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCS LARGE HOMO LOG 4 GENE; DRUG RESPONSE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENE REGULATORY NETWORKS; HUMANS; INTERFERON-BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MICRORNAS; MULTIPLE SCLEROSIS; RNA, SMALL UNTRANSLATED; SEQUENCE ANALYSIS, RNA; YOUNG ADULT;

EID: 84902662717     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-26     Document Type: Article

References (32)

1. Multiple sclerosis immunology: the healthy immune system vs the ms immune system. Kasper LH, Shoemaker J, Neurology 2010 74 2 S8 10.1212/WNL. 0b013e3181c97c8f 20038759
2. The genetics of multiple sclerosis: an update 2010. Hoffjan S, Akkad DA, Mol Cell Probes 2010 24 237 243 10.1016/j.mcp.2010.04.006 20450971
3. Non-coding RNAs with essential roles inneurodegenerative disorders. Salta E, De Strooper B, Lancet Neurol 2012 2 189 200
4. MicroRNAs and neurodegeneration: role and impact. Abe M, Bonini NM, Trends Cell Biol 2013 23 30 36 10.1016/j.tcb.2012.08.013 23026030
5. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. De Felice B, Guida M, Guida M, Coppola C, De Mieri G, Cotrufo R, Gene 2012 508 35 40 Epub 2012 Aug 8 10.1016/j.gene.2012.07.058 22903028
6. Small RNAs as guardians of the genome. Malone CD, Hannon GJ, Cell 2009 136 656 668 10.1016/j.cell.2009.01.045 19239887
7. Pathophysiology of translational regulation by micrornas in multiple sclerosis. Junker A, FEBS Lett 2011 585 3738 3746 10.1016/j.febslet.2011.03.052 21453702
8. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS, Ann Neurol 2005 58 840 846 10.1002/ana.20703 16283615 (Pubitemid 41746873)
9. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Kurtzke JF, Neurology 1983 33 1444 1452 10.1212/WNL.33.11.1444 6685237 (Pubitemid 14237132)
10. Clinical characteristics of responders to interferon therapy for relapsing MS. Waubant E, Vukusic S, Gignoux L, Dubief FD, Achiti I, Blanc S, Renoux C, Confavreux C, Neurology 2003 61 184 189 10.1212/01.WNL.0000078888. 07196.0B 12874396 (Pubitemid 36875298)
11. Predictors of relapse rate in MS clinical trials. Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research, Neurology 2005 65 1769 1773 10.1212/01.wnl.0000187122.71735.1f 16344520
12. Identification of microRNAs of the herpesvirus family. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T, Nat Methods 2005 2 269 276 10.1038/nmeth746 15782219 (Pubitemid 41131008)
13. Current tools for the identification of miRNA genes and their targets. Mendes ND, Freitas AT, Sagot MF, Nucleic Acids Res 2009 37 2419 2433 10.1093/nar/gkp145 19295136
14. Regulation of miRNA expression during neural cell specification. Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG, Eur J Neurosci 2005 21 1469 1477 10.1111/j.1460-9568.2005.03978.x 15845075 (Pubitemid 40646593)
15. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D, Brain 2005 128 1016 1025 10.1093/brain/awh467 15758036 (Pubitemid 40675457)
16. Human postsynaptic density-95 (PSD95): location of the gene (DLG4) and possible function in nonneural as well as in neural tissues. Stathakis DG, Hoover KB, You Z, Bryant PJ, Genomics 1997 44 71 82 10.1006/geno.1997.4848 9286702 (Pubitemid 27383341)
17. The homer family proteins. Shiraishi-Yamaguchi Y, Furuichi T, Genome Biol 2007 2 206
18. The emerging role of MicroRNAs in multiple sclerosis. Junker A, Hohlfeld R, Meinl E, Nat Rev Neurol 2011 7 56 59 10.1038/nrneurol.2010.179 21151203
19. MicroRNAs and multiple sclerosis. Tufekci KU, Oner MG, Genc S, Genc K, Autoimmune Dis 2011 2011 807426
20. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S, Scott RJ, Booth DR, Lechner-Scott J, ANZgene Multiple Sclerosis Genetics Consortium, PLoS One 2010 5 12132 doi:10.1371/journal.pone.0012132 10.1371/journal.pone.0012132 20711463
21. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Kishore S, Stamm S, Science 2006 311 230 232 10.1126/science. 1118265 16357227 (Pubitemid 43108188)
22. Small non-coding RNAs and genomic imprinting. Royo H1, Bortolin ML, Seitz H, Cavaillé J, Cytogenet Genome Res 2006 113 99 108 10.1159/000090820 16575168
23. Human box C/D snoRNAs with miRNA like functions expanding the range of regulatory RNAs. Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J, Nucleic Acids Res 2011 39 675 686 10.1093/nar/gkq776 20846955
24. The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader-Willi locus generate canonical box C/D snoRNAs. Bortolin-Cavaillé ML, Cavaillé J, Nucleic Acids Res 2012 40 1 8 10.1093/nar/gkr648 21908400
25. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG, Higgs DR, Nat Genet 2003 34 157 165 10.1038/ng1157 12730694 (Pubitemid 36666926)
26. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. Waschbisch A, Atiya M, Linker RA, Potapov S, Schwab S, Derfuss T, PLoS One 2011 6 24604 10.1371/journal.pone. 0024604 21949733
27. Glutamate and multiple sclerosis. Frigo M, Cogo MG, Fusco ML, Gardinetti M, Frigeni B, Curr Med Chem 2012 19 1295 1299 10.2174/092986712799462559 22304707
28. Glutamate in CNS neurodegeneration and cognition and its regulation by GCPII inhibition. Rahn KA, Slusher BS, Kaplin AI, Curr Med Chem 2012 19 1335 1345 10.2174/092986712799462649 22304712
29. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F, JNeurol 2003 250 1224 1228 (Pubitemid 37289657)
30. Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A, Brain Res 2007 7 1179 140 146 (Pubitemid 47633507)
31. Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Vanheel A, Daniels R, Plaisance S, Baeten K, Hendriks JJ, Leprince P, Dumont D, Robben J, Brône B, Stinissen P, Noben JP, Hellings N, PLoS One 2012 7 4 35544 10.1371/journal.pone.0035544 22530047
32. MicroRNAs as therapeutic targets. Czech MP, N Engl J Med 2006 354 1194 1195 10.1056/NEJMcibr060065 16540623